When considering Oculinum (botulinum toxin type A) injection for the treatment of strabismus, can the surgeon anticipate different results in patients who have had previous strabismus surgery?
Scott
A B
AB
Allergan Pharmaceuticals, Irvine, Calif.
D000328:Adult; D001905:Botulinum Toxins / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D012086:Reoperation; D013285:Strabismus / Q000628:therapy*; D016896:Treatment Outcome
D001905:Botulinum Toxins